Recall Register

Device recall: NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and…

Class III FDA enforcement event 92490. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Potential for lot number discrepancies between the test strip packaging and the barcode label applied to the test strip that is read by the instrument for LOT 123909 of NeuMoDx SARS-CoV-2 Test Strips (REF 300800). The instrument registers the non-human readable text as lot number 123910 from the barcode label.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

NeuMoDx Molecular Inc started this device recall on 15 May 2023. The firm address in the FDA record is in Ann Arbor, MI. FDA put the recall in Class III. FDA event 92490 has 1 product record. The first FDA enforcement report date is 12 Jul 2023. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.

Recalling firm

NeuMoDx Molecular Inc, Ann Arbor, MI.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 92490: product records
Recall numberProductQuantityClassStatusReport date
Z-2093-2023NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal swabs in transport medium and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider (HCP). REF Number: 3008001,086 test stripsClass IIIOngoing12 Jul 2023

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Device events that started in 2023
917
Share of these events in Class III
2%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
6

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 92490. https://recallregister.com/fda/iii/92490/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.
What quantity of product is in FDA event 92490?
The FDA record gives this quantity: 1,086 test strips
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2023 have the same class?
2% of the 917 device events that started in 2023 are in Class III.